A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering

NCT01684657 · clinicaltrials.gov ↗
PHASE3
Phase
SUSPENDED
Status
32
Enrollment
OTHER
Sponsor class

Stopped Study transferring to another facility

Conditions

Interventions

Sponsor

University of California, Irvine

Collaborators